Design Therapeutics News

Design Therapeutics | 10-Q: Quarterly report

May 8 16:55 ET

Design Therapeutics | 8-K: Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones

May 8 16:17 ET

Design Therapeutics | ARS: Annual Report to Security Holders

Apr 25 16:42 ET

Design Therapeutics | DEFA14A: Others

Apr 25 16:37 ET

Design Therapeutics | DEF 14A: Definitive information statements

Apr 25 16:36 ET

Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.

Mar 25 19:15 ET

Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berger Heather A.

Mar 25 19:10 ET

Design Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Kim Jae B.

Mar 20 20:03 ET

Design Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 19 16:28 ET

Design Therapeutics | 10-K: Annual report

Mar 19 16:23 ET

Design Therapeutics | 8-K: Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 19 16:21 ET

Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.3%),Citadel Advisors LLC(3.2%), etc.

Feb 14 17:06 ET

Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%), etc.

Feb 14 15:06 ET

Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.24%)

Jan 23 00:00 ET

Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burgess Julie

Jan 5 00:00 ET

Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jeffries Sean

Jan 5 00:00 ET

Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPPE RODNEY W

Dec 5, 2023 19:00 ET

Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Ansari Aseem Z.

Dec 5, 2023 18:57 ET

Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.

Nov 14, 2023 17:00 ET

Design Therapeutics: Q3 2023 Earnings Report

Nov 13, 2023 16:14 ET